For Media Interviews on Testing, Please See Information Below Following This Story.

LEXINGTON, Ky. (July 21, 2020) — The University of Kentucky on Tuesday detailed plans for testing up to 30,000 students for COVID-19 as part of its plan to restart in-class instruction on Aug. 17.

The testing details are the first in a series of announcements UK will make over the next few weeks regarding steps to protect the health, safety and well-being of the campus community as it prepares for the fall 2020 semester.

LEXINGTON, Ky. (July 22, 2020) — Early this spring, University of Kentucky virologist Rebecca Dutch answered some of our initial questions about COVID-19 and SARS-CoV-2, the virus that causes the disease. We asked her to take another look at the coronavirus pandemic.

LEXINGTON, Ky. (July 21, 2020) — A $3.2 million grant will support University of Kentucky College of Medicine research that could pave the way for a treatment for traumatic brain injury (TBI).

LEXINGTON, Ky. (July 17, 2020) — Researchers at the University of Kentucky Sanders-Brown Center on Aging (SBCoA) recently screened the first participant in the world for what is known as the AHEAD 3-45 study. This work is looking at a study medication, BAN2401, to determine if it can help prevent worsening memory and thinking among individuals who might be at risk for future decline. They are hoping this study finds that BAN2401 does just that and will ultimately help prevent Alzheimer’s disease.

Lexington, Ky. (July 1, 2020) - Beverly May, Dr.P.H., strives to empower rural communities to address the environmental issues that concern their health. As a family nurse practitioner in Appalachian Kentucky, May witnessed firsthand the environmental health effects caused by coal mining and natural gas drilling in the region.

Click here to read the full article on the NIEHS Partnerships for Environmental Public Health website.

LEXINGTON, Ky. (July 14, 2020) — Dennis E. Doherty, MD, professor emeritus of medicine at the University of Kentucky College of Medicine, has recently been named president of one of the world’s largest networks of global experts in science and health.

LEXINGTON, Ky. (July 14, 2020) — A new study by researchers at the University of Kentucky identifies a novel function of the enzyme spermine synthase (SMS) to facilitate colorectal cancer growth.

SMS is an enzyme that produces spermine from spermidine, which has been shown to be important for cell growth. However, excessive accumulation of spermidine can have harmful effects on cell viability. How cancer cells maintain a relatively high level of spermidine but below the toxic threshold to facilitate tumor growth is not well understood.

LEXINGTON, Ky. (July 14, 2020) - A time for action.

Drs. Li and Williams, in collaboration with physicians and faculty from the Department of Communication at the University of Kentucky, published findings from a study on the Interprofessional Teamwork Innovation Model in the Joint Commission Journal on Quality and Patient Safety.